MTOR and tuberous sclerosis: The next biological pathways most significantly enriched were the TRAIL signalling pathway, involved in apoptosis cascades (3.166‐fold enrichment), and the mTOR signalling pathway, the known intracellular driver of TSC tumours (2.990‐fold enrichment).